US 11390634
Fused heterocyclic compound
granted A61KA61K31/444A61K31/4985
Quick answer
US patent 11390634 (Fused heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/444, A61K31/4985, A61K31/5025, A61K31/519